More Than 50% of Health Care Professionals Oppose ACA

Share this content:
Many Health Care Professionals Oppose ACA Proposals
Many Health Care Professionals Oppose ACA Proposals

(HealthDay News) -- The majority of health care professionals are concerned about negative outcomes relating to enactment of the Affordable Care Act (ACA), although they recognize the benefits, according to a survey conducted by Coupa Software.

Researchers surveyed over 200 U.S. health care professionals on behalf of Coupa from Sept. 19 to 23, 2013, to examine their attitudes toward the new health care laws, focusing on current issues facing health care professionals.

According to the report, almost three-quarters of respondents (74%) felt there would be positive benefits once the ACA was fully enacted, including increased access to some level of coverage, increased preventive care services, and lower hospital bills and health care spending for taxpayers.

Ninety-three percent of respondents felt there could be negative consequences from the law, with 56% opposing most, if not all, of the proposals in the law. Negative consequences expected included decreases in the quality of health insurance policies as well as decreases in access and effectiveness of care.

"The administrative complexity of our health care system raises costs for health care providers and hampers their ability to provide excellent care to their patients," Amit Duvedi, vice president of business strategy at Coupa Software, said in a statement. "Implementing the ACA will force providers to do more with less as new enrollees sign up for coverage."

Related: The Affordable Care Act and its Potential in Oncology

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs